ARTICLE | Financial News
Medgenics completes follow-on
February 11, 2013 8:00 AM UTC
Medgenics Inc. (LSE:MEDU; NYSE-M:MDGN), Vienna, Va. Business: Gene/Cell therapy, Drug delivery Date completed: 2/8/13 Type: Follow-on Raised: $29.4 million Units: 5.6 million Price: $5.25 (unit) Share...